Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1945 - 1952 of 12143 results

CalPERS Fossil Fuel Divestment Bill Hinges On Union Support (1)
February 22, 2023| News

MintzTech Connect: All Things Technology — February 2023
February 21, 2023| Article| Viewpoint

Federal Judge Allows Antitrust Claims to Proceed Against Hospital System and Vertically-Integrated Physician Group
February 21, 2023| Blog| Viewpoint

Federal Court Kicks California Arbitration Ban to the Curb
February 21, 2023| Blog| Viewpoint

CMS Proposes New Disclosure of Ownership Regulations for Nursing Facilities - Top Five Takeaways for Private Equity Firms and REITs
February 21, 2023| Blog| Viewpoint

The Rise of Whistleblower Tips (and Rewards) for Crypto Sleuths
February 17, 2023| Blog| Viewpoint

Fifth Circuit Provides New Guidance on Evaluating Confidential Witnesses
February 16, 2023| Blog| Viewpoint

Ruling Casts Shadow On Cannabis Employees' Ch. 13 Relief
February 16, 2023| News
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts

Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|

Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
